Target intelligence / Profile preview

Nanog homeobox pseudogene (none)

Target
none
Molecular classification
Pseudogene, Homeobox gene related
01

Overview

Nanog homeobox pseudogenes are multiple non-coding derivatives of the functional Nanog homeobox gene (NANOG) spread across the human genome, designated as NANOGP1, NANOGP2, etc. [4]. They are not functional genes and do not encode proteins. NANOG itself is a master transcription factor required for the maintenance of embryonic stem cell pluripotency, but its pseudogenes have lost coding capacity through evolutionary processes. Although a few reports describe the transcription of some NANOG pseudogenes, and rare instances of mRNA detection in certain cancers, these pseudogenes do not function as receptors, enzymes, or therapeutic targets and have no confirmed physiological function or drug interactions [1][2][4]. The confusion sometimes arises because some pseudogenes are transcribed in specific cancers, but only the functional NANOG protein is considered an actionable therapeutic target in regenerative medicine and oncology [4]. Key points: - ENSG00000255356 represents a NANOG pseudogene, not the functional NANOG gene. - No drugs target this pseudogene; it is not an enzyme, receptor, transporter, or similar class. - Pseudogenes are sometimes reported as cancer biomarkers, but this is not an established or routine clinical use. - If you are referring to the canonical, protein-coding Nanog homeobox gene (NANOG), that is a different entity with distinct roles in stem cell biology and cancer; pseudogenes should not be listed as therapeutic targets [1][2][4].

Other names
NANOGP#NANOGP1NANOGP8Nanog pseudogene
02

Mechanism of action

none

03

Disease associations

Possible biomarker in certain cancers (unclear or controversial biological implications)
04

Biomarkers

Possible biomarker in cancer for some pseudogenes (e.g., NANOGP8 RNA)No established, validated biomarker use for this specific pseudogene

Beyond the preview

Go deeper on Nanog homeobox pseudogene (none).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanog homeobox pseudogene (none).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call